OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Berberine a traditional Chinese drug repurposing: Its actions in inflammation-associated ulcerative colitis and cancer therapy
Cuipeng Zhu, Kaiqi Li, Xiaoxu Peng, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 46

Showing 26-50 of 46 citing articles:

Berberine attenuates TNBS-induced colitis in mice by improving the intestinal microbiota
Chao Li, Xinxin Yin, Changpeng Xie, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 1

Berberine-Loaded PVCL-PVA-PEG Self-Assembled Micelles for the Treatment of Liver Fibrosis
Xinmin Zha, Yumei Hao, Yifan Ke, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 10857-10872
Open Access | Times Cited: 1

Recent studies on berberine and its biological and pharmacological activities.
Priscilla Nadalin, Yonggoo Kim, Sang Un Park
PubMed (2023) Vol. 22, pp. 315-328
Closed Access | Times Cited: 3

Natural products for treating cytokine storm–related diseases: Therapeutic effects and mechanisms
Mei Liu, Wang Qing, Wan-Ai Xu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115555-115555
Open Access | Times Cited: 2

Targeting oxidative stress with natural products: A novel strategy for esophageal cancer therapy
Fang Cao, Han-Ling Zhang, Cui Guo, et al.
World Journal of Gastrointestinal Oncology (2024) Vol. 16, Iss. 2, pp. 287-299
Open Access

Lacidipine inhibits NF-κB and Notch pathways and mitigates DSS-induced colitis
Xuezhao Yu, Li Cheng, Yu Tao, et al.
Research Square (Research Square) (2024)
Open Access

Lacidipine Inhibits NF-κB and Notch Pathways and Mitigates DSS-Induced Colitis
Xuezhao Yu, Li Cheng, Yu Tao, et al.
Digestive Diseases and Sciences (2024) Vol. 69, Iss. 10, pp. 3753-3759
Closed Access

Structural modifications of berberine and the lipid-regulating effects of its derivatives
Yun Lü, Mengxuan Yin, Yuting Lai, et al.
Medicinal Chemistry Research (2024)
Closed Access

Berberine: A multifaceted agent for lung cancer treatment-from molecular insight to clinical applications
Xiaodan Xu, He Yuanyuan, Jungang Liu
Gene (2024), pp. 149021-149021
Closed Access

Research Progress of Berberine in Treatment of Intestinal Diseases
奇梦 庞
Advances in Clinical Medicine (2024) Vol. 14, Iss. 11, pp. 15-20
Closed Access

Berberrubine, an Attractive derivative of berberine with multiple pharmacological activities
Yi Li, Gangmin Li, Cheng Peng, et al.
Arabian Journal of Chemistry (2024) Vol. 18, Iss. 1, pp. 106045-106045
Open Access

Inactivation of CYP2D6 by Berberrubine and the Chemical Mechanism
Jinqiu Rao, T. Wang, Linda Chia‐Hui Yu, et al.
Biochemistry (2024)
Closed Access

Xanthohumol ameliorates dextran sodium sulfate-induced colitis in mice by inhibiting of NF-κB signaling pathways and modulating intestinal microbiota
Ning Han, Jiakui Li, Yangyang Li, et al.
European Journal of Nutrition (2024) Vol. 64, Iss. 1
Closed Access

Comprehensive plasma metabolomics analysis of berberine treatment in ulcerative colitis rats by LC-MS/MS
Baodong Feng, Linqi Su, Yang Yang, et al.
Frontiers in Chemistry (2024) Vol. 12
Open Access

Previous Page - Page 2

Scroll to top